StemGenesis to market Vitro products in China
The agreement also covers Vitro Biopharma adult mesenchymal stem cell (MSC) lines and derivatives, MSC-Gro(TM) and LUMENESC(TM). Vitro Biopharma president and CEO Jim Musick said Vitro is pleased
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Imfinzi (durvalumab) in combination with Padcev (enfortumab vedotin) for adult patients with muscle-invasive bladder cancer (MIBC) who cannot receive or have refused cisplatin-based chemotherapy.
Marlex Pharmaceuticals’ s 12,000ft² facility contains temperature-controlled space and is used for pharmaceutical packaging, contract packaging and private labeling. The acquisition will increase revenues, order processing capability and